Chronic kidney disease (CKD) is a progressive and irreversible decline in kidney function that usually develops over many years. In the early stages, it can only be present in the form of biochemical abnormalities, with no noticeable symptoms. However, as the situation progresses, the kidneys gradually lose their ability to do the necessary emissions, metabolism and endocrine functions. This decline eventually consists of clinical manifestations of kidney failure, which is collectively known as Uramiia. When the kidney function deteriorates at the point where existence depends on the renal replacement therapy (RRT), the condition is classified as end-phase renal disease (ESRD) to suit the CKD stage 5.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
CKD is often found accidentally through regular blood tests. It is usually identified in high risk patients (eg, diabetes or high blood pressure).
Tangible in most patients. There may be some experiences: Nutturia (persistent urination at night) – due to loss of kidney focused capacity. It is a non-specific symptom.
Symptoms may appear to appear, still often unclear and non-specific: Tiredness Breathing (due to anemia or fluid overload)
Symptoms become more major and systemic, including: Itching (pruritus) Loss of appetite (anorexia) Decrease in load nausea and vomiting Hiccup
Deep breathing – due to metabolic acidosis Muscle Seizure (fit) Drowsiness and coma.
Haematuria and proteinuria may indicate glomerular disease and need for biopsy (p. 566).Proteinuria indicates risk of progressive CKD requiring preventive ACE inhibitor or ARB therapy
To identify hyperkalaemia and acidosis
Assessment of renal osteodystrophy
If anaemic, exclude common non-renal explanations, then manage as renal anaemia
Cardiovascular risk high in CKD: treat risk factors aggressively
Consider with obstructive urinary symptoms, persistent haematuria, family history of polycystic kidney disease or progressive CKD. Small kidneys suggest chronicity. Asymmetric renal size suggests renovascular or congenital disease
If dialysis or transplant is planned. Hepatitis B vaccination recommended if seronegative
Consider relevant tests from Box 18.26, especially if the cause of CKD is unknown (ACE = angiotensin-converting enzyme; ARB = angiotensin II receptor blocker; CKD = chronic kidney disease; HIV = human immunodeciency virus; 25(OH)D = 25-hydroxyvitamin D)
Copyright © 2025 – Designed by Camsol Advertising